---

William Chin

Chief Medical Officer and Executive Vice President, Scientific and Regulatory Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)

“While it is gratifying personally to be recognized in this way, I hope that it reflects an appreciation of the paramount importance of science and medicine in the biopharmaceutical industry. This is critical to sustain a pipeline of drugs that have the potential to help future patients live better lives and even to cure diseases,” says William.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016